Imatron revenues soar 147%

Article

Ultrafast CT developer Imatron is beginningto experience increased demand for its high-priced CT technology.The South San Francisco, CA, vendor reported last month that revenuesskyrocketed 147% for the second quarter (end-June). Imatron recorded

Ultrafast CT developer Imatron is beginningto experience increased demand for its high-priced CT technology.The South San Francisco, CA, vendor reported last month that revenuesskyrocketed 147% for the second quarter (end-June).

Imatron recorded revenues of $7.9 million for the quarter,a marked improvement over the $3.2 million reported in the sameperiod last year. Income was also up sharply. Imatron recordednet income of $447,000, compared to a net loss of $2.7 millionin the second quarter of 1993.

Imatron shipped four Ultrafast CT scanners during the quarterand achieved several other milestones in its technology developmentprojects, according to president and CEO Lewis Meyer.

Imatron has a CT development agreement with Siemens, whichmarkets the Imatron scanner as Evolution EBT (electron-beam tomography).Imatron also operates HeartScan Imaging, which provides UltrafastCT coronary artery scanning in company-owned clinics (SCAN 4/6/94).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.